Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@jonesallen99138 Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1965494997702377476.png) @jonesallen99138 jonesallen99138

jonesallen99138 posts on X about target, $arwr, $wve, $dnli the most. They currently have X followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1965494997702377476/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1965494997702377476/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX +30%

### Mentions: X [#](/creator/twitter::1965494997702377476/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1965494997702377476/c:line/m:posts_active.svg)


### Followers: X [#](/creator/twitter::1965494997702377476/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1965494997702377476/c:line/m:followers.svg)

- X Week X no change
- X Month X -XX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1965494997702377476/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1965494997702377476/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[target](/topic/target), [$arwr](/topic/$arwr) #4, [$wve](/topic/$wve) #38, [$dnli](/topic/$dnli), [$arvn](/topic/$arvn), [$11b](/topic/$11b), [$rna](/topic/$rna), [$srpt](/topic/$srpt), [$prqr](/topic/$prqr), [if you](/topic/if-you)

**Top accounts mentioned or mentioned by**
[@adamfeuerstein](/creator/undefined) [@pharmdca](/creator/undefined) [@avidresearch](/creator/undefined) [@drsprs](/creator/undefined) [@rnaianalyst](/creator/undefined) [@jonesallen234](/creator/undefined) [@statnews](/creator/undefined) [@hall8jack](/creator/undefined) [@titteridiot1](/creator/undefined) [@singlemalt18](/creator/undefined) [@morganstanley](/creator/undefined)

**Top assets mentioned**
[Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [Arvinas, Inc (ARVN)](/topic/$arvn) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Eli Lilly and Company (LLY)](/topic/$lly)
### Top Social Posts
Top posts by engagements in the last XX hours

"LRRK2 inhibitors are an interesting target in Parkinson's $DNLI $ARVN Neuron23. Long $DNLI with a few lottery calls. Data should be out first half next year"  
[X Link](https://x.com/jonesallen99138/status/1985019109629636965)  2025-11-02T16:20Z X followers, XXX engagements


"A drug platform that can effectively target diseases like DMI is worth $11B $RNA. If $SRPT DMI data is positive $ARWR is way undervalued especially given it's deep pipeline of other drugs. Long $ARWR $WVE and $PRQR"  
[X Link](https://x.com/jonesallen99138/status/1992974048456810888)  2025-11-24T15:10Z X followers, XXX engagements


"@Pharmdca If you could choose between a delay oral pill or a bi-annual/annual injection which do you think a majority of patients would choose"  
[X Link](https://x.com/jonesallen99138/status/1998421689194230236)  2025-12-09T15:57Z X followers, XXX engagements


"A preclinical RNAi obesity drug platform is worth $1.2B in bio bucks according to $LLY - this deal establishes a floor for valuing $WVE $ARWR clinical RNAi obesity platforms"  
[X Link](https://x.com/jonesallen99138/status/1998479155332264409)  2025-12-09T19:45Z X followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@jonesallen99138 Avatar @jonesallen99138 jonesallen99138

jonesallen99138 posts on X about target, $arwr, $wve, $dnli the most. They currently have X followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXX -XX%
  • X Month XXXXX +30%

Mentions: X #

Mentions Line Chart

Followers: X #

Followers Line Chart

  • X Week X no change
  • X Month X -XX%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks

Social topic influence target, $arwr #4, $wve #38, $dnli, $arvn, $11b, $rna, $srpt, $prqr, if you

Top accounts mentioned or mentioned by @adamfeuerstein @pharmdca @avidresearch @drsprs @rnaianalyst @jonesallen234 @statnews @hall8jack @titteridiot1 @singlemalt18 @morganstanley

Top assets mentioned Arrowhead Research Corporation (ARWR) Wave Life Sciences Ltd. Ordinary Shares (WVE) Denali Therapeutics Inc. Common Stock (DNLI) Arvinas, Inc (ARVN) Avidity Biosciences, Inc. Common Stock (RNA) Sarepta Therapeutics, Inc. (SRPT) Eli Lilly and Company (LLY)

Top Social Posts

Top posts by engagements in the last XX hours

"LRRK2 inhibitors are an interesting target in Parkinson's $DNLI $ARVN Neuron23. Long $DNLI with a few lottery calls. Data should be out first half next year"
X Link 2025-11-02T16:20Z X followers, XXX engagements

"A drug platform that can effectively target diseases like DMI is worth $11B $RNA. If $SRPT DMI data is positive $ARWR is way undervalued especially given it's deep pipeline of other drugs. Long $ARWR $WVE and $PRQR"
X Link 2025-11-24T15:10Z X followers, XXX engagements

"@Pharmdca If you could choose between a delay oral pill or a bi-annual/annual injection which do you think a majority of patients would choose"
X Link 2025-12-09T15:57Z X followers, XXX engagements

"A preclinical RNAi obesity drug platform is worth $1.2B in bio bucks according to $LLY - this deal establishes a floor for valuing $WVE $ARWR clinical RNAi obesity platforms"
X Link 2025-12-09T19:45Z X followers, XXX engagements

@jonesallen99138
/creator/twitter::jonesallen99138